Insider Transactions in Q4 2024 at Genprex, Inc. (GNPX)
Insider Transaction List (Q4 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price | 
|---|---|---|---|---|---|
| 
           
            Dec 05                          
            2024                          
           
         |           
        Toscano Jose Antonio Moreno Director | 
           
              BUY
             
            
                Grant, award, or other acquisition
             
           | 
        Direct | 
           
              4,750
              +37.71%
              
         |   
        
           
              -                 
                     
         | 
      
| 
           
            Dec 05                          
            2024                          
           
         |           
        Ryan M. Confer President, CEO and CFO | 
           
              BUY
             
            
                Grant, award, or other acquisition
             
           | 
        Direct | 
           
              29,375
              +42.88%
              
         |   
        
           
              -                 
                     
         | 
      
| 
           
            Dec 05                          
            2024                          
           
         |           
        Brent M Longnecker Director | 
           
              BUY
             
            
                Grant, award, or other acquisition
             
           | 
        Direct | 
           
              4,750
              +36.62%
              
         |   
        
           
              -                 
                     
         | 
      
| 
           
            Dec 05                          
            2024                          
           
         |           
        William R Wilson Jr. Director | 
           
              BUY
             
            
                Grant, award, or other acquisition
             
           | 
        Direct | 
           
              4,750
              +37.71%
              
         |   
        
           
              -                 
                     
         | 
      
| 
           
            Dec 05                          
            2024                          
           
         |           
        Mark Stanley Berger Chief Medical Officer | 
           
              BUY
             
            
                Grant, award, or other acquisition
             
           | 
        Direct | 
           
              18,250
              +44.18%
              
         |   
        
           
              -                 
                     
         |